Patients Won’t Get Vital Pancreatic Cancer Drug that can Extend Life on the NHS

*credit verbatim via Jenny Hope for the Daily Mail*

The first breakthrough drug for pancreatic cancer in 20 years will not be available on the NHS.

Hundreds of patients with advanced disease will be denied Abraxane, which extends life by two months when there are virtually no other options.

(click here to continue reading this article)

*credit verbatim via Jenny Hope for the Daily Mail*

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s